Sarin Arjun, Sharma Nikita, Jain Shobhit
Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri.
University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
Pediatr Qual Saf. 2021 Sep 24;6(5):e471. doi: 10.1097/pq9.0000000000000471. eCollection 2021 Sep-Oct.
The preprocedure time-out is an important safety measure to verify patient identity and accuracy of a planned procedure. The time-out is an institutional and Joint Commission requirement. However, physicians in our emergency departments (EDs) document it inconsistently. We aimed to improve physician preprocedure time-out documentation for deep sedation (ketamine and/or propofol) from 75% to 90%, and separately for cutaneous abscess incision and drainage (I&D) from 94% to 98% by June 2020.
We analyzed 1 year of baseline data and weekly electronic medical record (EMR) reports from November 2019 through June 2020. Our outcome measures were the rate of physician time-out documentation for deep sedation and I&D, respectively; our process measure was physician engagement. Our interventions included education, monthly reminders and updates, individualized feedback for insufficient documentation, EMR deep sedation, and I&D procedure note optimization, and academic and financial incentives. We used statistical process control chart quality improvement rules for discerning special versus common cause variation.
Physician documentation of a preprocedure time-out improved from 75% to 100% for deep sedation and from 94% to 99.3% for I&D. These improvements remained sustained. All physicians were eligible for the financial bonus, and 40 (63%) met Maintenance of Certification credit requirements.
Using quality improvement methodology, we increased physician time-out documentation for deep sedation and I&D through education, feedback, and systems enhancement. We improved Joint Commission regulatory compliance and reduced potential harm through these safety checks. Future studies may quantify patient safety effects and examine the efficacy of similar interventions for other procedures.
术前暂停是一项重要的安全措施,用于核实患者身份以及计划手术的准确性。术前暂停是机构和联合委员会的要求。然而,我们急诊科的医生对其记录并不一致。我们的目标是到2020年6月,将深度镇静(氯胺酮和/或丙泊酚)时医生术前暂停记录率从75%提高到90%,将皮肤脓肿切开引流术(I&D)的记录率从94%提高到98%。
我们分析了2019年11月至2020年6月的1年基线数据和每周电子病历(EMR)报告。我们的结果指标分别是深度镇静和I&D时医生术前暂停记录率;我们的过程指标是医生的参与度。我们的干预措施包括教育、每月提醒和更新、对记录不足的个性化反馈、EMR深度镇静和I&D手术记录优化,以及学术和经济激励。我们使用统计过程控制图质量改进规则来辨别特殊原因与常见原因的变异。
深度镇静时医生术前暂停记录从75%提高到了100%,I&D从94%提高到了99.3%。这些改进得以持续。所有医生都有资格获得经济奖励,40名(63%)符合继续医学教育学分要求。
通过采用质量改进方法,我们通过教育、反馈和系统强化,提高了深度镇静和I&D时医生术前暂停记录。我们提高了联合委员会监管合规性,并通过这些安全检查减少了潜在危害。未来的研究可以量化对患者安全的影响,并研究类似干预措施对其他手术的效果。